JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 74 filers reported holding JOUNCE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,438,000 | -15.1% | 375,000 | 0.0% | 0.30% | -26.4% |
| Q2 2018 | $2,873,000 | -79.8% | 375,000 | -40.9% | 0.40% | -83.9% |
| Q1 2018 | $14,192,000 | +134.3% | 635,000 | +33.7% | 2.50% | +69.2% |
| Q4 2017 | $6,056,000 | -2.8% | 475,000 | +18.8% | 1.48% | -16.1% |
| Q3 2017 | $6,229,000 | +177.5% | 399,825 | +149.9% | 1.76% | +111.9% |
| Q2 2017 | $2,245,000 | -21.5% | 160,000 | +23.1% | 0.83% | -50.8% |
| Q1 2017 | $2,859,000 | – | 130,000 | – | 1.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |